Showing results (11-20 of 85) with videos related to
Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1997
Salvage radiotherapy for local failures of lumpectomy and breast irradiationE E Mullen, M Deutsch, W D BloomerCancer Chemotherapy and Pharmacology|September 20, 2001
Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in miceM V Papadopoulou, M Ji, W D BloomerOncology Research|August 6, 2003
Synergistic interaction between cyclophosphamide or paclitaxel and the bioreductive compound NLCPQ-1, in vivoM V Papadopoulou, M Ji, W D BloomerJapanese Journal of Cancer Research : Gann|August 1, 1992
Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agentsM V Papadopoulou, A Mainwaring, W D BloomerInternational Journal of Radiation Oncology, Biology, Physics|December 9, 1998
NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivoM V Papadopoulou, M Ji, W D BloomerMedical Physics|June 1, 1997
Effective atomic numbers of composite materials for total and partial interaction processes for photons, electrons, and protonsS G Prasad, K Parthasaradhi, W D BloomerThe British Journal of Cancer. Supplement|July 1, 1996
THNLA-1 as radio/chemosensitiser of EMT-6 tumours in miceM V Papadopoulou, M Ji, W D BloomerMolecular Endocrinology (Baltimore, Md.)|September 1, 1988
A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumorsT Garcia, S Lehrer, W D Bloomer, et al.Cancer|March 1, 1990
Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumorsD E Merkel, W L McGuireHematology/Oncology Clinics of North America|December 1, 1989
Prognostic factors in breast cancerD E Merkel, C K OsbornePageof 9